Avestar Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.76M | Sell |
18,732
-286
| -2% | -$66.7K | 0.27% | 67 |
|
|
2026
Q1 | $4.65M | Buy |
19,018
+194
| +1% | +$45.2K | 0.3% | 60 |
|
|
2025
Q4 | $3.9M | Buy |
18,824
+1,093
| +6% | +$216K | 0.25% | 69 |
|
|
2025
Q3 | $3.29M | Buy |
17,731
+1,181
| +7% | +$202K | 0.22% | 86 |
|
|
2025
Q2 | $2.53M | Buy |
16,550
+1,692
| +11% | +$260K | 0.17% | 100 |
|
|
2025
Q1 | $2.46M | Buy |
14,858
+3,367
| +29% | +$527K | 0.21% | 90 |
|
|
2024
Q4 | $1.66M | Sell |
11,491
-1,599
| -12% | -$248K | 0.14% | 120 |
|
|
2024
Q3 | $2.12M | Buy |
13,090
+2,110
| +19% | +$336K | 0.22% | 86 |
|
|
2024
Q2 | $1.6M | Sell |
10,980
-1,524
| -12% | -$227K | 0.16% | 108 |
|
|
2024
Q1 | $1.98M | Buy |
12,504
+4,185
| +50% | +$666K | 0.21% | 94 |
|
|
2023
Q4 | $1.3M | Buy |
8,319
+1,225
| +17% | +$188K | 0.15% | 92 |
|
|
2023
Q3 | $1.1M | Buy |
7,094
+763
| +12% | +$126K | 0.16% | 86 |
|
|
2023
Q2 | $1.05M | Sell |
6,331
-4,084
| -39% | -$659K | 0.17% | 77 |
|
|
2023
Q1 | $1.61M | Sell |
10,415
-1,961
| -16% | -$317K | 0.29% | 53 |
|
|
2022
Q4 | $2.19M | Buy |
12,376
+1,416
| +13% | +$244K | 0.4% | 47 |
|
|
2022
Q3 | $1.79M | Buy |
10,960
+1,115
| +11% | +$189K | 0.46% | 44 |
|
|
2022
Q2 | $1.75M | Sell |
9,845
-289
| -3% | -$51.5K | 0.43% | 42 |
|
|
2022
Q1 | $1.8M | Buy |
10,134
+770
| +8% | +$131K | 0.29% | 73 |
|
|
2021
Q4 | $1.6M | Sell |
9,364
-641
| -6% | -$105K | 0.2% | 115 |
|
|
2021
Q3 | $1.62M | Sell |
10,005
-144
| -1% | -$24.6K | 0.21% | 116 |
|
|
2021
Q2 | $1.67M | Buy |
10,149
+1,356
| +15% | +$224K | 0.22% | 110 |
|
|
2021
Q1 | $1.42M | Sell |
8,793
-109
| -1% | -$17.6K | 0.32% | 66 |
|
|
2020
Q4 | $1.4M | Sell |
8,902
-148
| -2% | -$21.8K | 0.39% | 48 |
|
|
2020
Q3 | $1.3M | Sell |
9,050
-235
| -3% | -$34.8K | 0.43% | 37 |
|
|
2020
Q2 | $1.31M | Buy |
9,285
+2,844
| +44% | +$414K | 0.58% | 39 |
|
|
2020
Q1 | $845K | Sell |
6,441
-1,032
| -14% | -$146K | 0.46% | 55 |
|
|
2019
Q4 | $1.09M | Buy |
7,473
+54
| +0.7% | +$7.32K | 0.62% | 41 |
|
|
2019
Q3 | $960K | Buy |
7,419
+873
| +13% | +$115K | 0.6% | 39 |
|
|
2019
Q2 | $882K | Buy |
6,546
+19
| +0.3% | +$2.63K | 0.56% | 41 |
|
|
2019
Q1 | $883K | Sell |
6,527
-32
| -0.5% | -$4.29K | 0.58% | 40 |
|
|
2018
Q4 | $819K | Sell |
6,559
-22
| -0.3% | -$3.07K | 0.56% | 38 |
|
|
2018
Q3 | $881K | Buy |
6,581
+183
| +3% | +$24.3K | 0.51% | 35 |
|
|
2018
Q2 | $751K | Buy |
6,398
+122
| +2% | +$15.2K | 0.47% | 41 |
|
|
2018
Q1 | $784K | Buy |
6,276
+153
| +2% | +$20.7K | 0.51% | 37 |
|
|
2017
Q4 | $830K | Buy |
+6,123
| New | +$853K | 0.62% | 21 |
|
Other funds holding JNJ
AACR
Avestar Capital's JNJ Position: Q2 2026 in Review
Avestar Capital reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, selling an estimated $66.7K and leaving 18,732 shares worth $4.76M. The position accounts for 0.27% of the portfolio, ranked #67.
Avestar Capital first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. 2,348 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Avestar Capital held 18,732 shares of Johnson & Johnson worth $4.76M as of Q2 2026.
- Avestar Capital sold 286 Johnson & Johnson shares in Q2 2026, an estimated $66.7K.
- Johnson & Johnson made up 0.27% of Avestar Capital's portfolio in Q2 2026, its #67 holding.
- Avestar Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
- 2,348 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.